4DMedical Ltd (AU:4DX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
4DMedical Ltd has announced a change in the interests of its director, Andreas Fouras, with the acquisition of 775,339 unlisted options at an exercise price of $0.7534. These changes indicate a significant increase in Fouras’s stake, reflecting potential confidence in the company’s future performance. This update may interest investors keeping an eye on insider movements in the market.
For further insights into AU:4DX stock, check out TipRanks’ Stock Analysis page.